Kytogenics Pharmaceuticals Overview
- Founded
-
1991
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
Kytogenics Pharmaceuticals General Information
Description
Operator of a drug delivery and medical products platform designed to market a series of clinically significant therapies and products based on its N,O- carboxymethylchitosan (NOCC) derived technology and sulfated derivative s-NOCC. The company's platform focuses on the treatment of the mucosal disorders, interstitial cystitis and inflammatory bowel diseases, as well applies its technology to the delivery of peptides and other macromolecules, enabling patients to get faster relief and recovery from diseases.
Contact Information
Website
www.kytogenics.com
Formerly Known As
Chitogenics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Medical Supplies
Distributors/Wholesale (B2C)
Primary Office
- 466 Southern Boulevard
- Chatham, NJ 07928
- United States
+1 (973) 000-0000
Kytogenics Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Nov-2017 | 000.00 | Completed | Out of Business | ||
| 3. Later Stage VC | 20-May-2003 | 0000 | 000.00 | Completed | Generating Revenue | |
| 2. Later Stage VC | 18-Jul-2002 | $2.48M | $17.6M | Completed | Generating Revenue | |
| 1. Later Stage VC | $15.1M | $15.1M | Completed | Startup |
Kytogenics Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
